GALLI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.996
EU - Europa 1.698
AS - Asia 1.154
SA - Sud America 107
AF - Africa 28
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 21
Totale 6.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.956
RU - Federazione Russa 566
SG - Singapore 325
IT - Italia 292
CN - Cina 278
HK - Hong Kong 208
SE - Svezia 168
PL - Polonia 138
UA - Ucraina 127
IE - Irlanda 121
VN - Vietnam 117
KR - Corea 93
DE - Germania 90
BR - Brasile 82
FI - Finlandia 65
FR - Francia 63
IN - India 42
GB - Regno Unito 40
JO - Giordania 37
AU - Australia 25
CA - Canada 21
TR - Turchia 9
SC - Seychelles 8
CI - Costa d'Avorio 7
JP - Giappone 7
BD - Bangladesh 6
EG - Egitto 6
MX - Messico 6
CO - Colombia 5
IQ - Iraq 5
NL - Olanda 5
AZ - Azerbaigian 4
CL - Cile 4
EC - Ecuador 4
ID - Indonesia 4
JM - Giamaica 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BE - Belgio 3
EE - Estonia 3
GT - Guatemala 3
SA - Arabia Saudita 3
VE - Venezuela 3
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
ES - Italia 2
LB - Libano 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PY - Paraguay 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
Totale 6.011
Salva come PNG Salva come JPEG
Città #
Santa Clara 700
Ashburn 313
Singapore 228
Fairfield 203
Jacksonville 195
Hong Kong 179
Chandler 174
Warsaw 137
Dublin 121
Cambridge 109
Seattle 99
San Jose 93
Seoul 93
Woodbridge 85
Wilmington 82
Hefei 79
Houston 72
Milan 66
The Dalles 55
Beijing 54
Buffalo 49
Ann Arbor 40
Los Angeles 38
Ho Chi Minh City 36
Altamura 34
Boardman 34
Princeton 34
Lauterbourg 29
Boston 28
Hanoi 25
Melbourne 25
Lawrence 24
Mumbai 21
Rome 21
Paris 20
Kent 19
Shanghai 18
San Diego 17
Turku 16
Helsinki 15
Moscow 15
Washington 15
Dong Ket 14
Munich 14
Medford 13
Florence 12
São Paulo 12
Dallas 11
New York 11
Turin 11
Council Bluffs 10
West Jordan 8
Abidjan 7
Auburn Hills 7
Frankfurt am Main 7
Salerno 7
Tokyo 7
Chennai 6
Hillsboro 6
Izmir 6
Montreal 6
Naples 6
Orem 6
Andover 5
Cairo 5
Frankfurt Am Main 5
Norwalk 5
Venice 5
Baku 4
Chicago 4
London 4
Mexico City 4
Miano 4
Palermo 4
Philadelphia 4
Secaucus 4
St Louis 4
Toronto 4
Bologna 3
Brussels 3
Can Tho 3
Da Nang 3
Figino 3
Guangzhou 3
Haiphong 3
Padua 3
Puducherry 3
Redondo Beach 3
Stockholm 3
Tallinn 3
Verona 3
Amman 2
Baghdad 2
Barcelona 2
Bari 2
Bengaluru 2
Biên Hòa 2
Bogotá 2
Bắc Ninh 2
Dhaka 2
Totale 4.019
Salva come PNG Salva come JPEG
Nome #
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 341
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists 254
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 219
ANTINOCICEPTIVE ACTIVITY OF A 3(2H)-PYRIDAZINONE DERIVATE IN MICE 215
1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation and molecular modeling study 212
Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological and Molecular Modeling Studies 199
Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. 193
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists 191
4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones. Excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity 189
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 186
Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists 186
SYNTHESIS AND BINDING STUDY OF PYRAZOLO[4,5-C][1,8]NAPHTHYRIDINES. 182
Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity. 181
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 180
“3-Hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists” 180
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: synthesis and structure-activity relationships 177
Benzodiazepine binding activity of some tricyclic heteroarometic systems to define the hydrogen bonding strength of the proton donors of the receptor site. 175
7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists. 175
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 1-AMINOPHTHALAZINIUM SALTS AS GABAA RECEPTOR ANTAGONISTS. 171
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. 166
Synthesis and Pharmacological Studies at the Gly/NMDA, AMPA and Kainate Receptors of New Oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring 154
Synthesis, glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogs 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines. 152
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 149
Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs 148
Tandem 3D-QSARs Approach as a Valuable Tool To Predict Binding Affinity Data: Design of New Gly/NMDA Receptor Antagonists as a Key Study. 147
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. 147
Synthesis, Ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogue of TQX-173 138
Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity. 137
Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazolin-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. 128
Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation. 118
Pharmacokinetics of melphalan n (L-PAM) in true and mild hyperthermic perfusion in patients with melanoma of the lower limb. A preliminary report 117
Tricyclic Heteroaromatic systems. 3-Substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]quinoxalines as novel antagonists at the glycine-NMDA site. 111
Synthesis of 2-substituted-3,4-dihydro-3-oxo-6,8-dichloro-2H-1,4-benzothiazin-1,1-dioxides and 1-oxides as glycine-NMDA receptor antagonists. 111
Synthesis and structure-activity relationships of 1-aminophthalazinium bromides as GABAA receptor ligands. 104
Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and their constrained analogue imidazo[1,5-a]quinoxalines-1,3,4-triones as selective Glycine/NMDA receptor antagonists. 104
The guinea pig myenteric plexus as a tool to characterize drugs active at the glycine recognition site of the NMDA receptors. 93
Totale 6.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 24 9 11 8 7 8 16 10 5 66 48
2022/2023677 57 116 27 49 69 111 78 33 111 3 19 4
2023/2024267 9 32 48 17 19 56 10 43 3 8 13 9
2024/20251.739 52 164 90 221 549 274 13 143 54 54 71 54
2025/20261.621 232 255 144 61 206 63 188 61 84 84 36 207
2026/202757 49 8 0 0 0 0 0 0 0 0 0 0
Totale 6.030